Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 10NIH 3INDUSTRY 2NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 18Colorectal Neoplasms 16Breast Neoplasms 10Pancreatic Neoplasms 6Colonic Neoplasms 6Stomach Neoplasms 5Neoplasm Metastasis 4Gallbladder Neoplasms 3Bile Duct Neoplasms 3Uterine Cervical Neoplasms 2Somatostatinoma 2Esophageal Neoplasms 2Anus Neoplasms 2Anal Canal Carcinoma 2Adenoma, Islet Cell 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Insulinoma 1Inflammatory Breast Neoplasms 1Glucagonoma 1Gastro Oesophageal Cancer 1Gastrinoma 1Erythema Multiforme 1Central Nervous System Neoplasms 1

Interventions

sodium thiosulfate 1motexafin gadolinium 1ispinesib 1Restraint, Physical 1Radiotherapy 1Radiofrequency Ablation 1Psychiatric Rehabilitation 1Preoperative Exercise 1Polymerase Chain Reaction 1Platinum 1Mitomycin 1Gene Rearrangement 1Gene Expression Profiling 1Gemcitabine 1Fluorouracil 1Embolization, Therapeutic 1Doxorubicin 1Cytogenetic Analysis 1Cisplatin 1Capecitabine 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Liver Neoplasms × Capecitabine × Clear all
NCT00658593 2023-08-04

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Canadian Cancer Trials Group

Phase 3 Terminated
19 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡